Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
Newest: Medication errors: Causes, prevention, liability, and the apology
|
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
|
|
This month we would like to know...
Does your pharmacy use social media (blog, Facebook, Twitter, etc.) as a marketing tool?
• Yes
• No
• We plan on using social media in 2011
|
|
|
FDA recently announced its plans to remove certain unapproved prescription medicines used to treat cough, cold, and allergy symptoms. Read full article. |
 |
|
|
 |
A discussion generated by
Drug Topics’ readers, editorial staff, and advisory board
Nicole L. Ebisch, PharmD, CGP, FASCP, retail chain pharmacist,
Erie, Pa. |
Nitro-Levitra cocktail, anyone?
Read full article.
|
|
FDA has updated the pregnancy section of drug labels for the entire class of antipsychotic medications to provide more information about the potential risk of extrapyramidal signs and withdrawal symptoms in newborns whose mothers take antipsychotics during the third trimester of pregnancy. Read full article.
|
|
A new website, HealthCareandYou.org, has been created to educate pharmacists, other health professionals, and patients about the Affordable Care Act. Read full article.
|
|
The risk of certain birth defects is higher in women given opioid analgesics such as hydrocodone during pregnancy, a new study reported. Read full article.
|
|
Children 6 to 23 months of age who receive trivalent inactivated flu vaccine concurrently with the 13-valent pneumococcal conjugate vaccine are at increased risk of febrile seizures, according to researchers at the CDC and Harvard Medical School. Read full article.
|
|
FDA's Pulmonary-Allergy Drugs Advisory Committee voted to approve Novartis' QAB149 (indacaterol) 75 µg as a once-daily long-term maintenance bronchodilator treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema, PR Newswire reported. Read full article.
|
|
Walgreen Co., based in Deerfield, Ill., announced last Wednesday the sale of Walgreens pharmacy benefit management business, Walgreens Health Initiatives (WHI), to Catalyst Health Solutions Inc. of Rockville, Md., for $525 million in cash. Read full article.
|
|
Intuity Medical, Inc., the maker of POGO, a fully-integrated blood glucose monitoring system, secured a $20 million credit facility from Silicon Valley Bank and Oxford Finance Corporation. Read full article.
 |
Meetings and Events
March 24, 2011 Regional NACDS-DEA Meeting
10:00 a.m.-3:00 p.m.
Houston, Texas
Contact:
Magalie Normil
413 North Lee Street
Alexandria, VA
22313-1480
mnormil@nacds.org
March 25-27, 2011 NCPA Diabetes Accreditation Standards-Practical Applications (DASPA)
Dallas, TX
Contact:
100 Daingerfield Road
Alexandria, VA
22314
800-544-7447
March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734
April 16, 2011 Diabetes, Oral Health, & Nutrition: Interrelationships, Innovations, & Interventions
San Francisco, CA
Health professionals not eligible for continuing medical education credit will receive a certificate of participation
that they may submit to their state licensing board for credit.
Contact:
Joslin Diabetes Center
One Joslin Place
Boston, MA 02215
617-732-2400
www.ProfessionalEd.joslin.org
|
|
|
Drug Topics' readers
will be happy to know that the comment function for the blog on our homepage is now working properly. Please, join the discussion! |
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
 Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
